Reaction
Metabolic Surgery reporting signals
As of the last recalculation, Metabolic Surgery appears in 1,103 FAERS reports alongside 23 co-occurring drug terms. The strongest observed disproportionality signal is CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES (PRR 33.3).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Calcium, Magnesium, Potassium, And Sodium Oxybates | 15 | 33.3 | 33.4 |
| Lurasidone Hydrochloride | 21 | 19.3 | 19.3 |
| Risankizumab-Rzaa | 71 | 17.4 | 17.5 |
| Terazosin Hydrochloride | 8 | 17.1 | 17.1 |
| Sodium Oxybate | 44 | 13.1 | 13.1 |
| Labetalol | 9 | 12.8 | 12.8 |
| Eptinezumab-Jjmr | 6 | 12.5 | 12.5 |
| Upadacitinib | 48 | 11.6 | 11.6 |
| Oral Semaglutide | 40 | 10.6 | 10.6 |
| Etonogestrel | 24 | 9.7 | 9.7 |
| Etonogestrel And Ethinyl Estradiol | 11 | 9.4 | 9.4 |
| Esketamine Hydrochloride | 8 | 8.5 | 8.5 |
| Golimumab | 37 | 8.4 | 8.4 |
| Cariprazine | 4 | 8.1 | 8.1 |
| Tolvaptan | 6 | 7.8 | 7.8 |
| Liraglutide | 18 | 7.0 | 7.0 |
| Brexpiprazole | 6 | 6.9 | 6.9 |
| Naltrexone Hydrochloride And Bupropion Hydrochloride | 3 | 6.7 | 6.7 |
| Belimumab | 11 | 6.6 | 6.6 |
| Canagliflozin | 10 | 6.4 | 6.4 |
| Avapritinib | 4 | 6.3 | 6.3 |
| Elvitegravir, Cobicistat, Emtricitabine, And Tenofovir Alafenamide | 3 | 5.6 | 5.6 |
| Bimekizumab | 6 | 5.3 | 5.3 |